Published in Hepatitis Weekly, June 24th, 2002
Omega interferon is a naturally occurring human interferon manufactured by BioMedicines, Inc., through genetic engineering.
"We have enrolled our 90th patient in this multicenter study," said Peter J. Langecker, MD, PhD, vice president of clinical affairs. "Because the drug has been so well tolerated to date, we have been able to continue to increase the weekly dose. Higher doses have meant higher response rates."
Mark Moran, chief executive officer, said, "Therapy with omega...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.